Bioequivalence study of Sulfasalazine for Chile [Regulatives / Guidelines]

posted by manojskr – India, 2013-09-09 17:10 (4671 d 02:10 ago) – Posting: # 11463
Views: 2,174

Dear All,
Please suggest the analytes to be measured and bioequivalence to be established based on, for a BE stduy of Sulfasalazine in plasma for Chile region. Considering Sulfasalazine a prodrug and having low bioavailability whether analysis of 5-aminosalicylic acid and sulphapyridine is required for establishing bioequivalence of sulfasalazine for Chile region? Whether scaling is permitted for sulfasalazine 500mg dose up to 3-4 folds.

Kind Regards,
Manoj Singh

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
141 visitors (0 registered, 141 guests [including 24 identified bots]).
Forum time: 19:21 CEST (Europe/Vienna)

Scientists often have a naïve faith that
if only they could discover enough facts about a problem,
these facts would somehow arrange themselves
in a compelling and true solution.    Theodosius Dobzhansky

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5